Table 4 Individual tumor and kidney absorbed dose predictions versus observations for [¹⁷⁷Lu]Lu-HA-DOTATATE, followed by calculated RPEs per patient (ID2–ID10)

Tumor

 Observed

24.4

14.4

29.3

38.3

8.67

34.4

19.5

12.4

27.7

 Predicted

21.3

17.4

19.6

18.7

5.62

25.5

28.1

12.1

21.5

 RPE

−13%

21%

−33%

−51%

−35%

−26%

44%

−3%

−23%

Kidney

 Observed

–

3.12

2.21

1.19

5.38

3.92

3.79

4.41

3.71

 Predicted

–

2.57

2.57

2.69

2.17

2.26

2.81

2.51

2.75

 RPE

–

33%

−18%

21%

82%

−58%

−28%

−34%

−38%